OTC Pharmaceuticals Marktreport 2022

Statista Health Market Outlook

OTC Pharmaceuticals Marktreport 2022 The steady improvement in human development and access to medicines will continue to impact the OTC Pharmaceuticals market. Overall, the OTC Pharmaceuticals market realized a revenue of US$129 billion worldwide in 2021.

In this report, growth potentials, market drivers, consumer insights, key companies and future developments for three major OTC Pharmaceuticals markets, North America, Europe and Asia, will be discussed.


What's included?
  • Market Overview and all relevant sales figures
  • Consumer insights and trends
  • Key players - Johnson & Johnson, GlaxoSmithKline, Bayer AG
  • Segment deep dives
  • KPI comparison: Sales and growth rates
  • Country and regional comparison
  • Market forecasts
BeschreibungInhaltTabellen

The Over-the-counter (OTC) Pharmaceuticals market comprises prescription-free medicines. They are common treatment for physicians and patients when it comes to minor diseases. The market is divided into six segments: Analgesics, Cough & Cold Remedies, Digestives & Intestinal Remedies, Skin Treatment, Vitamins & Minerals and Hand Sanitizer.

This report from the series of Consumer Market Outlook reports gives an overview of the OTC Pharmaceuticals market from an international perspective. Besides all relevant market figures like total and per capita revenues for the years from 2016 to 2027, we furthermore give detailed insights into current trends, key players and important background information on the OTC Pharmaceuticals market.

In general, the OTC Pharmaceuticals market is expected to grow at a CAGR of 5% between 2022 and 2027. Particularly strong growth is expected in middle-income countries, as the infrastructure is being further expanded. But over-the-counter pharmaceuticals will continue to show high positive growth in OECD countries as well, as patients often receive preventive services.

The Cough & Cold Remedies and Analgesics segments together account for more than half of total revenue, especially due to the major sales of Aspirin, Paracetamol, Ibuprofen, and remedies against flu-like infections.

Note: CAGR: Compound Annual Growth Rate / average growth rate per year

  • Sprache: Englisch
  • Veröffentlicht: September 2022
  Melden
Jetzt Studie kaufen
Über 7.500
Unternehmen vertrauen
Statista

Empfohlene Studien & Dossiers

Aktuelle Studien & Dossiers

Verwandte Statistiken

Sie haben noch Fragen?

Kontaktieren Sie uns schnell und einfach.
Wir helfen Ihnen gern!

Möglichkeiten der Kontaktaufnahme

Nutzen Sie gern unser Kontaktformular oder unsere FAQ.
Alternativ können Sie sich auch direkt an unseren Kundenservice wenden.

Ihr Kontakt
Jens Weitemeyer
Client Service CE

Mo - Fr von 9:30 bis 17:00

Weiter zum Report Download

E-Mail-Adressen werden niemals verkauft oder weitergegeben.
Die Adresse wird ausschließlich genutzt um Statista Produktinfos und Angebote mitzuteilen.

Datenschutz

Menü